Cargando…

Corrigendum: PGC-1α silencing compounds the perturbation of mitochondrial function caused by mutant SOD1 in skeletal muscle of ALS mouse model

Detalles Bibliográficos
Autores principales:	Qi, Yan, Yin, Xiang, Wang, Shuyu, Jiang, Hongquan, Wang, Xudong, Ren, Ming, Feng, Honglin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771923/ https://www.ncbi.nlm.nih.gov/pubmed/26973512 http://dx.doi.org/10.3389/fnagi.2016.00037

Ejemplares similares

PGC-1α Silencing Compounds the Perturbation of Mitochondrial Function Caused by Mutant SOD1 in Skeletal Muscle of ALS Mouse Model
por: Qi, Yan, et al.
Publicado: (2015)

An examination of wild-type SOD1 in modulating the toxicity and aggregation of ALS-associated mutant SOD1
por: Prudencio, Mercedes, et al.
Publicado: (2010)

A novel SOD1-ALS mutation separates central and peripheral effects of mutant SOD1 toxicity
por: Joyce, Peter I., et al.
Publicado: (2015)

SOD1 silencing in motoneurons or glia rescues neuromuscular function in ALS mice
por: Dirren, Elisabeth, et al.
Publicado: (2015)

Better survival in female SOD1-mutant patients with ALS: a study of SOD1-related natural history
por: Tang, Lu, et al.
Publicado: (2019)

Correction to: Better survival in female SOD1-mutant patients with ALS: a study of SOD1-related natural history
por: Tang, Lu, et al.
Publicado: (2019)

SUMO3 Modification Accelerates the Aggregation of ALS-Linked SOD1 Mutants
por: Niikura, Takako, et al.
Publicado: (2014)

Parkin is a disease modifier in the mutant SOD1 mouse model of ALS
por: Palomo, Gloria M, et al.
Publicado: (2018)

Structural Properties and Interaction Partners of Familial ALS-Associated SOD1 Mutants
por: Huai, Jisen, et al.
Publicado: (2019)

Guanabenz Treatment Accelerates Disease in a Mutant SOD1 Mouse Model of ALS
por: Vieira, Fernando G., et al.
Publicado: (2015)

A VDAC1-Derived N-Terminal Peptide Inhibits Mutant SOD1-VDAC1 Interactions and Toxicity in the SOD1 Model of ALS
por: Shteinfer-Kuzmine, Anna, et al.
Publicado: (2019)

Functional skeletal muscle model derived from SOD1-mutant ALS patient iPSCs recapitulates hallmarks of disease progression
por: Badu-Mensah, Agnes, et al.
Publicado: (2020)

SOD1-positive aggregate accumulation in the CNS predicts slower disease progression and increased longevity in a mutant SOD1 mouse model of ALS
por: Gill, Cindy, et al.
Publicado: (2019)

Modulation of SOD1 Subcellular Localization by Transfection with Wild- or Mutant-type SOD1 in Primary Neuron and Astrocyte Cultures from ALS Mice
por: Lee, Do-Yeon, et al.
Publicado: (2015)

Mutant SOD1 Increases APP Expression and Phosphorylation in Cellular and Animal Models of ALS
por: Rabinovich-Toidman, Polina, et al.
Publicado: (2015)

Pro-Oxidant Activity of an ALS-Linked SOD1 Mutant in Zn-Deficient Form
por: Nagao, Chise, et al.
Publicado: (2020)

Characterization of the activity, aggregation, and toxicity of heterodimers of WT and ALS-associated mutant Sod1
por: Brasil, Aline de Araújo, et al.
Publicado: (2019)

ALS mutant SOD1 interacts with G3BP1 and affects stress granule dynamics
por: Gal, Jozsef, et al.
Publicado: (2016)

ALS-associated mutant SOD1(G93A )causes mitochondrial vacuolation by expansion of the intermembrane space and by involvement of SOD1 aggregation and peroxisomes
por: Higgins, Cynthia MJ, et al.
Publicado: (2003)

PAK4 suppresses motor neuron degeneration in hSOD1(G93A)‐linked amyotrophic lateral sclerosis cell and rat models
por: Cong, Chaohua, et al.
Publicado: (2021)

Anti-SOD1 Nanobodies That Stabilize Misfolded SOD1 Proteins Also Promote Neurite Outgrowth in Mutant SOD1 Human Neurons
por: Kumar, Meenakshi Sundaram, et al.
Publicado: (2022)

ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2
por: Pedrini, Steve, et al.
Publicado: (2010)

Early Interneuron Dysfunction in ALS: Insights from a Mutant sod1 Zebrafish Model
por: McGown, Alexander, et al.
Publicado: (2013)

Distinct partitioning of ALS associated TDP-43, FUS and SOD1 mutants into cellular inclusions
por: Farrawell, Natalie E., et al.
Publicado: (2015)

A molecular chaperone activity of CCS restores the maturation of SOD1 fALS mutants
por: Luchinat, Enrico, et al.
Publicado: (2017)

ALS-Linked SOD1 Mutants Enhance Neurite Outgrowth and Branching in Adult Motor Neurons
por: Osking, Zachary, et al.
Publicado: (2018)

ALS-Linked SOD1 Mutants Enhance Neurite Outgrowth and Branching in Adult Motor Neurons
por: Osking, Zachary, et al.
Publicado: (2019)

ALS-Related Mutant SOD1 Aggregates Interfere with Mitophagy by Sequestering the Autophagy Receptor Optineurin
por: Tak, Yeong Jin, et al.
Publicado: (2020)

Copper-ATSM as a Treatment for ALS: Support from Mutant SOD1 Models and Beyond
por: Nikseresht, Sara, et al.
Publicado: (2020)

Strategies to promote the maturation of ALS-associated SOD1 mutants: small molecules return to the fold
por: McAlary, Luke, et al.
Publicado: (2019)

First Principles Calculation of Protein–Protein Dimer Affinities of ALS-Associated SOD1 Mutants
por: Hsueh, Shawn C. C., et al.
Publicado: (2022)

Impaired ATF3 signaling involves SNAP25 in SOD1 mutant ALS patients
por: Yazar, Volkan, et al.
Publicado: (2023)

Increased surface P2X4 receptors by mutant SOD1 proteins contribute to ALS pathogenesis in SOD1-G93A mice
por: Bertin, Eléonore, et al.
Publicado: (2022)

Regulation of PGC-1α Isoform Expression in Skeletal Muscles
por: Popov, D. V., et al.
Publicado: (2015)

Corrigendum: Comprehensive expression analysis with cell-type-specific transcriptome in ALS-linked mutant SOD1 mice: Revisiting the active role of glial cells in disease
por: Yamashita, Hirofumi, et al.
Publicado: (2023)

Widespread aggregation of mutant VAPB associated with ALS does not cause motor neuron degeneration or modulate mutant SOD1 aggregation and toxicity in mice
por: Qiu, Linghua, et al.
Publicado: (2013)

Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS
por: Bosco, Daryl A., et al.
Publicado: (2010)

A diacidic motif determines unconventional secretion of wild-type and ALS-linked mutant SOD1
por: Cruz-Garcia, David, et al.
Publicado: (2017)

A Synthetic SOD/Catalase Mimic Compound for the Treatment of ALS
por: Soll, Matan, et al.
Publicado: (2021)

Impact of EcSOD Perturbations in Cancer Progression
por: O’Leary, Brianne R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nkce1cnstumcrh311v06utln5d